World Alzheimer’s Day is celebrated every year on September 21. On this day, the world focuses on raising awareness of Alzheimer’s disease. The disease is one of the most common forms of dementia; a set of disorders that disrupt mental functioning. World Alzheimer’s Day is the perfect time to raise our voices and find new ways to fight the effects of the disease.
The theme of World Alzheimer’s Day 2022 is the power of knowledge. Understanding dementia, how it affects people, the warning signs and how to support those who have it is critical to the well-being of many people. The theme emphasizes the importance of understanding all aspects of the disease.
Alzheimer’s disease is often called a family disease because the chronic stress of a loved one’s slow decline affects everyone. 5.7 million Americans are living with Alzheimer’s disease. Alzheimer’s disease is the sixth leading cause of death in the United States and the only cause of death in the top 10 in the United States that cannot be prevented, cured or even slowed. As life expectancy increases and baby boomers come of age, supporting Alzheimer’s research is more important to our families than ever.
Globally, dementia is one of the biggest challenges we face, with nearly 50 million people living with dementia worldwide. To tackle the global dementia challenge, we need to work together, collaborate and share best practices. Clinical trials are the key to the development of medicine. Through clinical trials, researchers are testing new ways to detect, treat, and prevent Alzheimer’s disease and related dementias. Without clinical trials, there can be no new treatments or cures.
GCT focuses on CNS and Neurology trials and has been running trials in Alzheimer’s Disease since 2001. We are closely familiar with Key Opinion Leaders (KOLs) and the best clinical sites worldwide. Reach out to GCT at bd@gctrials.com for more information.